文献速递皮肤感染毛发、甲与色素性疾病

非皮肤癣菌霉菌性甲真菌病综述:流行病学、诊断与管理

A comprehensive review of nondermatophyte mould onychomycosis: Epidemiology, diagnosis and management.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2023-11-27

非皮肤癣菌霉菌(NDM)可在病甲中检出,但致病或污染难辨。经重复培养确认侵袭性存在的研究中,NDM在甲真菌病患者中全球患病率约6.9%,常见属为曲霉、帚霉和镰刀菌。临床可似皮肤癣菌甲真菌病,诊断需镜检见真菌丝且无皮肤癣菌时至少两次独立分离出NDM,分子检测联合组织学可提高敏感性。

要点

  • NDM甲真菌病全球患病率约6.9%,常见属为曲霉、帚霉和镰刀菌。
  • 近端甲下型伴甲沟炎提示曲霉、镰刀菌或短帚霉;浅白型深弥漫提示曲霉或镰刀菌。
  • 诊断需镜检见真菌丝、无皮肤癣菌且至少两次独立分离出NDM。

核心结论

  • NDM在甲真菌病中全球患病率约6.9%,常见属为曲霉、帚霉和镰刀菌。
  • NDM甲真菌病临床可与皮肤癣菌甲真菌病难以区分,但某些特征提示NDM。
  • 抗真菌药敏试验在多数情况下价值有限。

研究设计与样本

  • 综述,检索范围未明确报告。

主要发现

  • 经重复培养确认NDM侵袭性存在的研究中,NDM在甲真菌病患者中全球患病率约6.9%。
  • 最常见的3个属为曲霉、帚霉和镰刀菌。
  • 近端甲下型伴甲沟炎与曲霉、镰刀菌和短帚霉相关。
  • 浅白型深弥漫模式与曲霉和镰刀菌相关。
  • 远端侧位甲下型中的纵向条纹可能为额外指示。

关键数值与推荐

  • 诊断需光镜见与NDM一致的真菌丝,且无皮肤癣菌时至少两次独立分离出NDM。
  • 分子检测联合组织学评估可作为替代,敏感性和周转时间改善。
  • 特比萘芬和伊曲康唑(连续和脉冲)对曲霉、镰刀菌或帚霉所致甲真菌病程度不等有效。
  • 新帚霉属口服治疗文献稀少。

临床怎么用

  • 对疑似NDM甲真菌病,应重复培养确认侵袭性存在,避免将污染误判为致病。
  • 镜检见真菌丝且无皮肤癣菌时,需至少两次独立分离出NDM方可诊断。
  • 分子检测联合组织学可提高诊断敏感性和周转时间。
  • 多数情况抗真菌药敏试验价值有限,治疗可选用特比萘芬或伊曲康唑。

局限性

  • NDM甲真菌病有效治疗信息相对稀少。
  • 新帚霉属口服治疗文献稀少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Nondermatophyte moulds (NDMs) are widely distributed and can be detected in association with mycotic nails; however, sometimes it can be challenging to establish the role of NDMs in the pathogenesis of onychomycosis (i.e. causative vs. contaminant). In studies where the ongoing invasive presence of NDMs is confirmed through repeat cultures, the global prevalence of NDMs in onychomycosis patients is estimated at 6.9% with the 3 most common genus being: Aspergillus, Scopulariopsis and Fusarium. NDM onychomycosis can, in many cases, appear clinically indistinguishable from dermatophyte onychomycosis. Clinical features suggestive of NDMs include proximal subungual onychomycosis with paronychia associated with Aspergillus spp., Fusarium spp. and Scopulariopsis brevicaulis, as well as superficial white onychomycosis in a deep and diffused pattern associated with Aspergillus and Fusarium. Longitudinal streaks seen in patients with distal and lateral onychomycosis may serve as an additional indicator. For diagnosis, light microscopic examination should demonstrate fungal filaments consistent with an NDM with at least two independent isolations in the absence of a dermatophyte; the advent of molecular testing combined with histological assessment may serve as an alternative with improved sensitivity and turnover time. In most instances, antifungal susceptibility testing has limited value. Information on effective treatments for NDM onychomycosis is relatively scarce, unlike the situation in the study of dermatophyte onychomycosis. Terbinafine and itraconazole therapy (continuous and pulsed) appear effective to varying extents for treating onychomycosis caused by Aspergillus, Fusarium or Scopulariopsis. There is scant literature on oral treatments for Neoscytalidium.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Gupta AK, Wang T, Cooper EA, et al. A comprehensive review of nondermatophyte mould onychomycosis: Epidemiology, diagnosis and management. J Eur Acad Dermatol Venereol. 2023. PMID: 38010049. doi:10.1111/jdv.19644

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。